ArticleOncology reports2026
Hypoxic CAF studies unveil PTHrP‑vitamin D‑RAS axis as pivotal in the CAF.
Article in Oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer‑associated fibroblasts (CAFs) play critical roles in the tumor microenvironment (TME); however, their characteristics under hypoxic conditions remain incompletely understood. The aim of the present study was to investigate the properties of hypoxic CAFs and identify their regulatory factors in colorectal cancer (CRC). CAFs cultured under normoxic and hypoxic conditions were analyzed using proliferation assays, co‑culture experiments, shotgun proteomics and single‑cell RNA sequencing. Clinical specimens were evaluated immunohistochemically using the desmoplastic reaction (DR) classification. In addition, the generalizability of the findings was validated by correlation analyses using The Cancer Genome Atlas database. Hypoxic CAFs showed enhanced proliferative capacity, and their conditioned medium promoted migration and chemoresistance in CRC cells. Shotgun proteomics revealed a significant increase in vitamin D‑binding protein in the conditioned media of hypoxic CAFs, while single‑cell RNA sequencing showed enrichment of genes related to bone metabolism and the phosphoinositide 3‑kinase‑AKT signaling pathway. Treatment of normal fibroblasts (NFs) with parathyroid hormone‑related protein (PTHrP) induced CAF‑like phenotypes, whereas treatment of CAFs with vitamin D led to morphological changes toward a NF‑like appearance. In clinical samples, the immature DR subtype, associated with poor prognosis, exhibited increased expression of the hypoxia marker hypoxia‑inducible factor‑1α, periostin and PTHrP, along with a significant association with Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations. Furthermore, a strong positive correlation was observed between the copy numbers of PTHrP and KRAS across multiple cancer types, including CRC. These findings suggest that the PTHrP‑vitamin D‑rat sarcoma oncogene (RAS) axis functions as an important regulatory mechanism in hypoxic CAFs. PTHrP and vitamin D may influence each other's activity, and this axis may contribute to tumor progression within the TME. Therefore, the PTHrP‑vitamin D‑RAS axis could serve as a potential therapeutic target.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.